Stay updated on Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added results posting information and new outcomes for the study, including DFS definitions and adverse-event metrics with follow-up times, and linked a PDF of the Study Protocol and SAP. The page's study documents section was updated and some prior analysis details were removed.
    Difference
    3%
    Check dated 2026-01-28T06:28:40.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and the previous v3.3.3 revision was removed, representing a minor technical update with no changes to study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:07:11.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    A new Locations section appears with Texas as a study site. The previous Texas Locations entry and the HHS Vulnerability Disclosure link were removed; the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T17:25:23.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The study results status changed from No Results Posted to Results Submitted, indicating that the trial results are now being prepared for posting. This affects the availability of outcome information for stakeholders reviewing the study.
    Difference
    0.1%
    Check dated 2025-12-16T10:13:44.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.2.0 to v3.3.2 on the page.
    Difference
    0.1%
    Check dated 2025-11-24T21:32:59.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The notice about a lapse in government funding and operating status has been removed from the page; this does not affect the study details or how the page functions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T20:03:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial page.